4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000004
GENERAL COUNSEL & CORP SEC acquired 25,475 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise | +7,475 | 19,731 | D | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise | +6,000 | 25,731 | D | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise | +12,000 | 37,731 | D | ||
| Derivatives | |||||||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise · Restricted Stock Units | −7,475 | 7,475 | D | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise · Restricted Stock Units | −6,000 | 12,000 | D | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-15 | Option exercise · Restricted Stock Units | −12,000 | 36,000 | D | ||
Loading xslF345X05/form4-03172026_090341.xml…